Allergenic Products Advisory Committee Meeting Cancellation

Summary

The FDA has canceled a meeting of the Allergenic Products Advisory Committee originally scheduled for May 15, 2020, to allow time for the FDA to review outstanding issues related to the safety and efficacy of Peanut Allergen Extract manufactured by DBV Technologies, S.A. The FDA will reschedule the meeting as needed to continue evaluating the product.